Phase Forward Inc.

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Our award-winning technology and global services are designed to enable life sciences companies of all types and sizes to automate and integrate the management of their entire clinical development process – from study initiation and FDA submission through post-marketing studies. Our products and services have been used in over 10,000 clinical trials involving more than 1,000,000 trial study participants at over 300 life sciences companies, medical device firms, regulatory agencies and public health organizations.
Phase Forward is a publicly held company (NASDAQ: PFWD) with corporate headquarters in Waltham, Massachusetts, international headquarters in Maidenhead, UK and regional offices in the U.S., Japan, France and Australia.
Contact Details
Executives
Chairman, President, and CEO
Robert K. (Bob) Weiler
SVP, CFO, and Treasurer
Christopher (Chris) Menard